Rimon
 Save as PDF
RSS Feed Subscribe

Rimon Attorneys Attend Texcap Conference and North American Blockchain Summit

events Rimon Attorneys Attend Texcap Conference and North American Blockchain Summit Theodore (Ted) Ghorra · Rimon Attorneys Attend Texcap Conference and North American Blockchain Summit Gavin Fearey · Rimon Attorneys Attend Texcap Conference and North American Blockchain Summit Nick Curley · October 27, 2025

Rimon attorneys Ted Ghorra, Gavin Fearey, and Nick Curley attended the Texcap Conference in Dallas on October 8, which was a fantastic opportunity to network with clients, the Global Managing Director of Listings at the Texas Stock Exchange, and representatives of NASDAQ and NYSE Texas. Gavin and Nick then attended the North American Blockchain Summit…

Continue Reading…

Neuphoria Therapeutics Ring the Nasdaq Opening Bell

news Neuphoria Therapeutics Ring the Nasdaq Opening Bell Theodore (Ted) Ghorra · Neuphoria Therapeutics Ring the Nasdaq Opening Bell Andrew Reilly · Neuphoria Therapeutics Ring the Nasdaq Opening Bell Elaine Wangsawidjaja · Neuphoria Therapeutics Ring the Nasdaq Opening Bell Olivia Y. Wang · March 6, 2025

We congratulate our client, Neuphoria Therapeutics Inc. on their successful redomiciliation to the U.S. In celebratory fashion, Neuphoria Therapeutics Inc. rang the Nasdaq Opening Bell on March 3rd, 2025!  Ted Ghorra, Andrew Reilly, Elaine Wangsawidjaja and Olivia Wang have worked regularly with this client. Read more here Rimon’s Securities and Capital Markets attorneys have decades…

Continue Reading…

Rimon advises Aussie biotech on re-domiciliation and listing on Nasdaq as a Delaware company

news Rimon advises Aussie biotech on re-domiciliation and listing on Nasdaq as a Delaware company Andrew Reilly · Rimon advises Aussie biotech on re-domiciliation and listing on Nasdaq as a Delaware company Theodore (Ted) Ghorra · Rimon advises Aussie biotech on re-domiciliation and listing on Nasdaq as a Delaware company Craig Tanner · Rimon advises Aussie biotech on re-domiciliation and listing on Nasdaq as a Delaware company Elaine Wangsawidjaja · January 23, 2025

Rimon is proud to have acted as US counsel to Bionomics Limited, an Australian clinical-stage biotechnology company, on its re-domiciliation to the United States and the successful listing of its new Delaware parent company (Neuphoria Therapeutics Inc.) on Nasdaq. Such a re-domiciliation involves an Australian statutory scheme of arrangement under which, following approval by shareholders…

Continue Reading…

U.S. Law Guide for U.S. Companies on ASX

insights U.S. Law Guide for U.S. Companies on ASX Andrew Reilly · U.S. Law Guide for U.S. Companies on ASX Theodore (Ted) Ghorra · U.S. Law Guide for U.S. Companies on ASX Alberto Pacchioni · August 7, 2023

Rimon Partner, Andrew Reilly, explores the reasons why many U.S. companies choose to undertake an initial public offering (IPO) and list on the Australian Securities Exchange (ASX). Currently, over 20 U.S. incorporated companies and approximately 30 Australian incorporated companies with U.S. headquarters are listed on ASX. The purpose of this guide is to assist U.S.…

Continue Reading…

Tauriga Sciences, Inc. announces signing of major distribution agreement with online grocer and wholesaler, Stock Up Express

news Tauriga Sciences, Inc. announces signing of major distribution agreement with online grocer and wholesaler, Stock Up Express Theodore (Ted) Ghorra · January 26, 2021

Rimon advised life sciences company Tauriga Sciences Inc. in the preparation of its distribution agreement with Stock Up Express, a leading distribution company. Under the terms of the agreement, Stock Up Express will market and resell Tauri-Gum™, the Tauriga Sciences Inc. line of CBD & CBG infused supplement chewing gum, to its large and diverse…

Continue Reading…

Rimon Law Welcomes Seasoned Transactional Lawyer Theodore Ghorra as Partner in its New York Office

news Rimon Law Welcomes Seasoned Transactional Lawyer Theodore Ghorra as Partner in its New York Office Theodore (Ted) Ghorra · September 4, 2018

Rimon Law welcomes corporate and capital markets attorney Theodore Ghorra, who has closed hundreds of corporate and capital market transactions, as a Partner on their Corporate Team in the firm’s New York office. Mr. Ghorra joins Rimon from Nixon Peabody LLP, where he was a Partner. Among the hundreds of transactions closed by Mr. Ghorra include public and private offerings,…

Continue Reading…

Rimon Law
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.